Washington [US], August 1 (ANI): According to a new study led by Vanderbilt University Medical Center, a biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients.
Washington [US], July 27 (ANI): A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study led by Vanderbilt University Medical Center.